Evaluation of the morphine reversal actions and antinociceptive activity of a new class of opiate antagonists structurally related to fentanyl

Richard L. Wynn,Jerome R. Bagley,H. Kenneth Spencer,Theodore C. Spaulding
DOI: https://doi.org/10.1002/ddr.430220209
1991-01-01
Drug Development Research
Abstract:Structural changes to the fentanyl molecule based on heterocyclic modifications at the sector distal to the piperidine nitrogen results in morphine reversal activity. A series of such compounds known as 4‐(heteroanilido) piperidines were tested for reversal of morphine antinociception and depressed respiration rate per minute (RPM) using a rabbit tooth pulp model. Nine compounds were tested and all reversed morphine depressed RPM with doses ranging from 0.007 mg/kg to 1.55 mg/kg. Four of the nine compounds also significantly reversed antinociception at doses ranging from 0.005 mg/kg to 0.6 mg/kg. All but one compound elicited significant antinociception in non‐morphine rabbits. Maximum possible effect (MPE) ranged from 21% to 57% and cumulative doses to achieve antinociception ranged from 0.16 mg/kg to 7.7 mg/kg. These compounds increased RPM in non‐morphine rabbits with a range from 9% to 49% over control values. A furan ring at the distal site was found to be important in selective reversal of RPM. When a methylated 2‐pyridine was combined with a 2‐furan, reversal of both morphine antinociception and depressed RPM was achieved. One compound in this series compared favorably to the mixed agonist‐antagonist nalbuphine and a second compared favorably to the pure antagonist naloxone.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?